Abstract
This review provides an overview of the recent data evaluating triglyceride and low-density lipoprotein (LDL) size, two highly interrelated, genetically influenced, risk factors for cardiovascular disease (CVD). An examination of new epidemiologic studies continues to demonstrate that plasma triglyceride levels predict CVD. The first prospective study of the familial forms of hypertriglyceridemia has shown that relatives in familial-combined hyperlipidemia families are at increased risk for CVD mortality and that triglyceride levels predicted 20-year, CVD mortality among relatives in familial hypertriglyceridemia families. A meta-analysis of three, large-scale, prospective studies in men, and the first study to examine the correlation of LDL particle size distribution and vascular changes measured by B-mode ultrasound, add to growing evidence that small, dense LDL is atherogenic. Quantitative genetic analysis has recently shown substantial pleiotropic (common) genetic effects on triglyceride and LDL size. At least part of this may be explained by variation at the cholesterol ester transfer protein locus on chromosome 16, possibly through its role in reverse cholesterol transport. Taken together, these data provide new insights into the importance of triglyceride and LDL particle size for understanding genetic susceptibility to cardiovascular disease and its prevention.
Similar content being viewed by others
References and Recommended Reading
Hulley SB, Rosenman RH, Bawol RD, Brand RJ: Epidemiology as a guide to clinical decisions: the association between triglyceride and coronary heart disease. N Engl J Med 1980, 302: 1383–1389.
Criqui MH, Heiss G, Cohn R, et al.: Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med 1993, 328: 1220–1225.
Austin MA: Triglycerides and coronary heart disease. Arterioscler Thromb 1991, 11: 2–14.
NIH Consensus Development Panel on Triglyceride High-Density Lipoprotein and Coronary Heart Disease: Triglyceride, high-density lipoprotein, and coronary heart disease. JAMA 1993, 269:505–510.
Gotto AM: Triglylceride: the forgotten risk factor. Circulation 1998, 97: 1027–1028.
Brunzell JD, Schrott HG, Motulsky AG, Bierman EL: Myocardial infarction in the familial forms of hypertriglyceridemia. Metabolism 1976, 25: 313–320.
Goldstein JL, Schrott HG, Hazzard WR, et al.: Hyperlipidemia in coronary heart disease: II. genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 1973, 52: 1544–1568.
Nikkila EA, Aro A: Family study of serum lipids and lipoproteins in coronary heart-disease. Lancet 1973, 1: 954–959.
Austin MA, King M-C, Vranizan KM, Krauss RM: Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. Circulation 1990, 82: 495–506.
Grundy SM: Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am J Cardiol 1998, 81: 18B-25B.
Austin MA, Hokanson JE, Brunzell JB: Characterization of LDL subclasses: methodological approaches and clinical relevance. Curr Opin Lipidol 1994, 5: 395–403.
Austin MA, Breslow JL, Hennekens Ch, et al.: Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988, 260: 1917–1921.
Griffin BA, Freeman DJ, Tait GW, et al.: Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 1994, 106: 241–253.
Mahaney MC, Blangero J, Comuzzie AG, et al.: Plasma HDL cholesterol, triglycerides, and adiposity: a quantitative genetic test of the conjoint trait hypothesis in the San Antonio Family Heart Study. Circulation 1995, 92: 3240–3248.
McNamara JR, Jenner JL, Li Z, et al.: Change in LDL particle size is associated with change in plasma triglyceride concentration. Arterioscler Thromb 1992, 12: 1284–1290.
Selby JV, Austin MA, Newman B, et al.: LDL subclass phenotypes and the insulin resistance syndrome. Circulation 1993, 88: 381–387.
Edwards KL, Austin MA, Newman B, et al.: Multivariate analysis of the insulin resistance syndrome. Arterioscler Thromb 1994, 14: 1940–1945.
Stampfer MJ, Krauss RM, Ma J, et al.: A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 1996, 276: 882–8.
Austin MA, Mykkänen L, Kuusisto J, et al.: A prospective study of small, dense LDLs and non-insulin dependent diabetes in the elderly. Circulation 1995, 92: 1770–1778.
Haffner SM, Mykkänen L, Valeez RA, et al.: LDL size and subclass pattern in a biethnic population. Arterioscler Thromb 1993, 13: 1623–1630.
Austin MA, King M-C, Vranizan KM, Krauss RM: Inheritance of low density lipoprotein subclass patterns: results of complex segregation analysis. Am J Hum Genet 1988, 43: 838–846.
Austin MA, Brunzell JD, Fitch WL, Krauss RM: Inheritance of low-density lipoprotein subclass patterns in familial combined hyperlipidemia. Arteriosclerosis 1990, 10: 520–30.
Bredie SJ, Kiemeney LA, de Haan AF, et al.: Inherited susceptibility determines the distribution of dense low- density lipoprotein subfraction profiles in familial combined hyperlipidemia. Am J Hum Genet 1996, 58: 812–822.
de Graaf J, Swinkels DW, de Haan AFJ, et al.: Both inherited susceptibility and environmental exposure determine the low-density lipoprotein-subfraction pattern distribution in healthy Dutch families. Am J Hum Genet 1992, 51: 1295–1310.
Austin MA, Newman B, Selby JV, et al.: Genetics of low-density lipoprotein subclass phenotypes in women twins: concordance, heritability and commingling analysis. Arterioscler Thromb 1993, 13: 687–695.
Lamon-Fava S, Jimenez D, Christian JC, et al.: The NHLBIT win Study: heritability of apolipoprotein A-I, B, and low density lipoprotein subclasses and concordance for lipoprotein(a). Atherosclerosis 1991, 91: 97–106.
Dreon DM, Fernstrom HA, Miller B, Krauss RM: Low-density lipoprotein subclass patterns and lipoprotein response to a reduced-fat diet in men. FASEB J 1994, 8: 121–126.
Dreon DM, Fernstrom HA, Williams PT, Krauss RM: LDL subclass patterns and lipoprotein response to a low-fat, high-carbohydrate diet in women. Arterioscler Thromb Vasc Biol 1997, 17: 707–714.
Hokanson JE, Austin MA: Triglyceride is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol: a meta-analysis of population-based prospective studies. J Cardio Risk 1996, 3: 213–219.
Jeppsen J, Hein HO, Suadicani P, Byntelberg F: Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation 1998, 97: 1029–1036.
Haim M, Benderly M, Brunner D, et al.: Elevated serum triglyceride levels and long-term mortality in patients with coronary heart disease: the Bezafibrate Infarction Prevention (BIP) registry. Circulation 1999, 100: 475–482.
Austin MA, McKnight B, Edwards KL, et al.: Cardiovascular disease mortality in the familial forms of hypertriglyceridemia: a twenty-year prospective study. Circulation 2000, in press.
Tenkate L: Increased frequency of coronary heart disease in relatives of wives of myocardial infarct survivors: assortative mating for lifestyle and risk factor? Am J Cardiol 1984, 53: 399–403.
Chait A, Albers JJ, Brunzell JD: Very low-density lipoprotein overproduction in genetic forms of hypertriglyceridaemia. Eur J Clin Invest 1980, 10: 17–22.
Kissebah AH, Alfarsi S, Evans DJ: Low-density lipoprotein metabolism in familial combined hyperlipidemia: mechanism of the multiple lipoprotein phenotypic expression. Arteriosclerosis 1984, 4: 614–624.
Janus ED, Nicoll AM, Turner PR, et al.: Kinetic bases of the primary hyperlipidaemias: studies of apolipoprotein B turnover in genetically defined subjects. Eur J Clin Invest 1980, 10: 161–172.
Brunzell JD, Albers JJ, Chait A, et al.: Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. J Lipid Res 1983, 24: 147–155.
Sniderman A, Shapiro S, Marpole D, et al.: Association of coronary atherosclerosis with hyperapobetalipoproteinemia: increased protein but normal cholesterol levels in human plasma low density (b) lipoproteins. Proc Natl Acad Sci USA 1980, 77: 604–608.
Duane WC: Abnormal bile acide adsorption in familial hypertriglyceridemia. J Lipid Res 1995, 36: 96–107.
Angelin B, Hershon KS, Brunzell JD: Bile acid metabolism in hereditary form of hypertriglyceridemia: evidence for an increased synthesis rate in monogenic familial hypertriglyceridemia. Proc Natl Acad Sci USA 1987, 84: 5434–5438.
Ellen RLB, McPherson R: Long-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia. Am J Cardiol 1998, 81 (4A): 60B-65B.
Ooi TC, Heinonen T, Alaupovic P, et al.: Efficacy and safety of a new hydorxymethylglutaryl-coenzyme A reducase inhibitor, Atorvastatin, in patients with familial combined hyperlipidemia: comparison with Fenofibrate. Arteroscler Thromb Vasc Biol 1997, 17: 1793–1799.
Gardner CD, Fortmann SP, Krauss RM: Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 1996, 276: 875–81.
Lamarche B, Tchernof A, Moorjani S, et al.: Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study. Circulation 1997, 95: 69–75.
Krauss RM, Burke DJ: Identification of multiple subclasses of plasma low-density lipoprotein in normal humans. J Lipid Res 1982, 23: 97–104.
Austin MA, Rodriguez BL, McKnight B, et al.: Low-density lipoprotein(LDL) particle size and plasma triglyceride(TG) as predictors of coronary heart disease in older Japanese American men [abstract]. Circulation 1997, 96 (Suppl I).
Gray RS, Robbins DC, Wang W, et al.: Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American Indians: the Strong Heart Study. Arterioscler Thromb Vasc Biol 1997, 17: 2713–2720.
Mykkanen L, Kuusisto J, Haffner SM, et al.: LDL size and risk of coronary heart disease in elderly men and women. Arterioscler Thromb Vasc Biol 1999, 19: 2742–2748.
Ruotolo G, Tettamanti C, Garancini MP, et al.: Smaller, denser LDL particles are not a risk factor for cardiovascular disease in healthy nonagenarian women of the Cremona Population Study. Atherosclerosis 1998, 140: 65–70.
Kamigaki AS, Siscovick DS, Schwartz SM, et al.: Risk of early-onset myocardial infarction associated with decreased low density lipoprotein size in women [abstract]. Circulation 1999, 99: 1107.
Skoglund-Anderson C, Tang R, Bond GM, et al.: LDL particle size distribution is associated with cardotid intima-media thickness in healthy 50-year old men. Arterioscler Thromb Vasc Biol 1999, 19: 2422–2430.
Edwards KL, Mahaney MC, Motulsky AG, Austin MA: Pleiotropic genetic effects on low-density lipoprotein size, plasma triglyceride, and high density lipoprotein cholesterol in families. Arterioscler Thromb Vasc Biol 1999, 19: 2456–2464.
Talmud PJ, Edwards KE, Turner CM, et al.: Linkage of the cholesterol ester transfer protein (CETP) gene to LDL particle size: Use of a novel tetranucleotide repeat within the CETP promoter. Circulation 2000, in press.
Rainwater DL, Almasy L, Blangero J, et al.: A genome search identifies major quantitative trait loci on human chromosomes 3 and 4 that influence cholesterol concentrations in small LDL particles. Arterioscler Thromb Vasc Biol 1999, 19: 777–783.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Austin, M.A. Triglyceride, small, dense low-density lipoprotein, and the atherogenic lipoprotein phenotype. Curr Atheroscler Rep 2, 200–207 (2000). https://doi.org/10.1007/s11883-000-0021-4
Issue Date:
DOI: https://doi.org/10.1007/s11883-000-0021-4